Immunogenicity and acceptability of a human diploid-cell culture rabies vaccine in volunteers
- PMID: 47083
- DOI: 10.1016/s0140-6736(75)91761-4
Immunogenicity and acceptability of a human diploid-cell culture rabies vaccine in volunteers
Abstract
A rabies vaccine, prepared in human diploid-cell culture, was given intradermally (i.d.) or intramuscularly (i.m.) to 35 volumteers who had not previously received prophylactic immunisation. Rabies neutralising antibody titres rose sharply after the first dose, and 4 weeks after the second dose all titres were above 1/80 (1-7 i.u. per ml.). Immunisation via the i.d. and i.m. routes was equally successful in terms of likely immune status, but the i.d. rate was associated with many more local sideeffects.
Similar articles
-
Safety and immunogenicity of a new purified vero cell rabies vaccine (PVRV) administered by intramuscular and intradermal routes in healthy volunteers.Vaccine. 2013 May 31;31(24):2719-22. doi: 10.1016/j.vaccine.2013.03.050. Epub 2013 Apr 12. Vaccine. 2013. PMID: 23583817 Clinical Trial.
-
Failure to achieve predicted antibody responses with intradermal and intramuscular human diploid cell rabies vaccine.Lancet. 1984 May 19;1(8386):1098-100. doi: 10.1016/s0140-6736(84)92509-1. Lancet. 1984. PMID: 6144829 Clinical Trial.
-
Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial.Lancet. 2017 Sep 23;390(10101):1511-1520. doi: 10.1016/S0140-6736(17)31665-3. Epub 2017 Jul 25. Lancet. 2017. PMID: 28754494 Clinical Trial.
-
Rabies antibody titers in vaccinees: protection, failure and prospects.Int J Clin Pharmacol Ther Toxicol. 1992 Mar;30(3):107-12. Int J Clin Pharmacol Ther Toxicol. 1992. PMID: 1506120 Review.
-
Intradermal rabies vaccination: the evolution and future of pre- and post-exposure prophylaxis.Curr Top Microbiol Immunol. 2012;351:139-57. doi: 10.1007/82_2010_121. Curr Top Microbiol Immunol. 2012. PMID: 21267707 Review.
Cited by
-
Prophylactic immunization of humans against rabies by intradermal inoculation of human diploid cell culture vaccine.J Clin Microbiol. 1976 Feb;3(2):96-101. doi: 10.1128/jcm.3.2.96-101.1976. J Clin Microbiol. 1976. PMID: 1254722 Free PMC article.
-
Persistence of rabies antibody 5 years after pre-exposure prophylaxis with human diploid cell antirabies vaccine and antibody response to a single booster dose.Epidemiol Infect. 1987 Aug;99(1):91-5. doi: 10.1017/s0950268800066899. Epidemiol Infect. 1987. PMID: 3609177 Free PMC article.
-
High rate of insufficient antibody titers after single-day immunization with human diploid-cell-strain vaccine against rabies.Klin Wochenschr. 1986 Jun 2;64(11):518-21. doi: 10.1007/BF01713059. Klin Wochenschr. 1986. PMID: 3723999 Clinical Trial.
-
Fractional dose of intradermal compared to intramuscular and subcutaneous vaccination - A systematic review and meta-analysis.Travel Med Infect Dis. 2020 Sep-Oct;37:101868. doi: 10.1016/j.tmaid.2020.101868. Epub 2020 Sep 6. Travel Med Infect Dis. 2020. PMID: 32898704 Free PMC article.
-
Ethylenimine-inactivated rabies vaccine of tissue culture origin.J Clin Microbiol. 1976 Jan;3(1):26-33. doi: 10.1128/jcm.3.1.26-33.1976. J Clin Microbiol. 1976. PMID: 1254701 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources